News & Events

We are proud to share a new study from our members Dr. Athan Baillet and Dr. Denis Mulleman, regarding the search for precision medicine in axial spondyloarthritis (axSpA). The Study: Serum…

We are pleased to share our latest research outcome from the STSM published in Psoriasis: Targets and Therapy (Dove Medical Press), identifying key genetic drivers in psoriasis lesions. 🧬 Summary:…

We are thrilled to announce the publication of our latest paper: “Statement on education and scientific research in the field of therapeutic drug monitoring by the COST Action ENOTTA CA21147.”…

Last week, the COST Action ENOTTA (CA21147) successfully hosted its Biomarker Training School at the University of Manchester, UK. Following opening remarks by Prof. Denis Mulleman, Action Chair, trainees from…

We are pleased to share a new publication from COST Action ENOTTA (CA21147) entitled:  “From reactive to predictive: Advancing biologic dosing in dermatology” Biologic therapies have transformed the management of…

The COST Action ENOTTA (CA21147) – 2nd International Conference and Management Committee Meeting was successfully held in Madrid, Spain, from 10–12 December 2025. The event brought together researchers, clinicians, and…

We are pleased to announce that our Working Group members have published a new paper in the jounal, Basic & Clinical Pharmacology & Toxicology entitled: “Quality Assessment of Therapeutic Drug…

📢 New Publication from the Members of ENOTTA in the British Journal of Clinical Pharmacology We are proud to announce that ENOTTA members have published the paper “Therapeutic drug monitoring…

The Extended Core Group Meeting of the ENOTTA (CA21147) COST Action was successfully held on 10–12 September 2025 in Berlin, Germany. Over the course of three highly productive days, core…

Call for Applications – ENOTTA Biomarkers Training School COST Action ENOTTA (CA21147) is excited to invite applications for the Biomarkers Training School, taking place 4–6 February 2026 at the University…